Nantes, October 3, 2025, 8:00 a.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) announces the termination of the position as chief executive officer of Mr. Nicolas Poirier and the ...
Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results